Benefits firms shouldn't play drug favorites: CEO
Matthew J. Belvedere | @Matt_Belvedere
Watch Video
Regeneron Pharmaceuticals' CEO told CNBC on Tuesday that benefits companies should not try to practice medicine.
Dr. Leonard Schleifer was reacting to the recent news that Express Scripts, the country's largest pharmacy benefits manager, dropped reimbursement for Gilead Science's hepatitis C treatment because it got deep discounts from an AbbVie alternative.
Read more....
No comments:
Post a Comment